| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.04B | — | +23.6% |
| Cost of Revenue | $558.1M | — | +11.6% |
| Gross Profit | $486.1M | — | +41.2% |
| R&D Expense | $66.9M | — | +27.8% |
| SG&A Expense | $65.3M | — | +22.9% |
| Operating Income | $345.3M | — | +56.1% |
| Pre-tax Income | $354.3M | — | +63.2% |
| Income Tax | $7.7M | — | +2.5% |
| Net Income | $346.6M | — | +65.4% |
| EPS (Basic) | $3.23 | — | +64.8% |
| EPS (Diluted) | $3.22 | — | +65.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.36B | -15.7% | +182.1% |
| Accounts Receivable | $1.37B | +6.2% | -14.4% |
| Inventory | $893.9M | +21.3% | -30.5% |
| Current Assets | $5.65B | -6.4% | +23.4% |
| Total Assets | $13.35B | +0.2% | +10.2% |
| Current Liabilities | $2.21B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$214.9M | — | +64.7% |
| Capital Expenditures | $118.5M | — | -42.5% |
| Investing Cash Flow | -$148.5M | — | -68.4% |
| Financing Cash Flow | -$72.2M | — | +27.5% |
| Free Cash Flow | -$333.4M | — | +59.0% |
| -6.9% |
| Long-term Debt | $237.2M | -16.1% | -27.7% |
| Total Liabilities | $3.47B | -8.2% | -11.6% |
| Stockholders' Equity | $9.88B | +3.6% | +20.7% |